Skip to main content

Psoriasis Treatment Market to Cross USD 40.58 Billion by 2027; Increasing Prevalence of Psoriatic Arthritis to Aid Growth, says Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, July 09, 2020 (GLOBE NEWSWIRE) — The global psoriasis treatment market size is projected to reach USD 40.58 billion by the end of 2027. Increasing focus on development of biologics for psoriasis treatment will aid the growth of the overall market in the coming years. According to a report published by Fortune Business Insights, titled “Psoriasis Treatment Market Size, Share & Covid-19 Impact Analysis, By Drug Class (TNF inhibitors, Interleukins, and Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, and Others), By Route of Administration (Oral, Parenteral/Systemic, and Topical) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2020-2027,” the market was worth USD 20.09 billion in 2019 and will exhibit a CAGR of 9.2% during the forecast period, 2020-2027.The symptoms of psoriasis include red patches, itchiness, rashes, and irritation. The increasing medical activities associated with the condition and the growing emphasis on the development of efficient treatment options will emerge in favor of the growth of the overall psoriasis treatment market in the foreseeable future.Market to Remain Unaffected by Ongoing Covid-19 PandemicThe recent coronavirus outbreak has questioned the performance of various business sectors across the world. Several debates are being conducted; with regard to the effect of the outbreak and predictions are being set out at a rapid pace. Despite the severity of the pandemic, it is unlikely that this outbreak will restrict the performance of the companies in the psoriasis treatment market.
Browse Summary of this Research Report with Detailed Table of Content:The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
To get the short-term and long-term impact of COVID-19 on this Market.Please visit: https://www.fortunebusinessinsights.com/industry-reports/psoriasis-treatment-market-100600
The report encompasses several factors that have contributed to the growth of the overall psoriasis treatment market in recent years. Among all factors, the increasing number of regulatory usage approvals by leading organizations such as the Food and Drug Administration has had the highest impact on the growth of the market. The report highlights a few of the major FDA approvals of recent times and discusses their impact on the growth of the overall market.In April 2019, Ortho Dermatologics announced that it has received approval from the FDA for a lotion in treatment of patients suffering from psoriasis. The company received approval for use of ‘Duobrii’ for treatment of plaque psoriasis. The product will be used in adults suffering from plaque psoriasis. Several efforts are being made for the development of newer products, in tandem with Duobrii for the treatment of other serious psoriasis conditions.The report analyses the latest market trends across five major regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among all regions, the market in North America is projected to emerge dominant in the coming years. The increasing prevalence of psoriasis and several conditions associated with this disease.The growing demand for novel treatment options for this disease will aid the growth of the regional market. As of 2019, the market in North America was worth 8.48 billion and this value is projected to increase at a considerable pace in the coming years. The market in Asia Pacific is projected to exhibit the highest CAGR in the coming years driven by the presence of several large scale companies in several countries across this region.
List of the Leading Companies Operating in the Psoriasis Treatment Market are:AbbVie Inc. (Illinois, United States)Novartis AG (Basel, Switzerland)Johnson & Johnson Services, Inc. (New Jersey, United States)Pfizer Inc., (New York, United States)LEO Pharma A/S (Ballerup, Denmark)Merck & Co., Inc. (New Jersey, United States)Amgen Inc. (California, United States)Eli Lilly and Company (Indiana, United States)CELGENE CORPORATION (New Jersey, United States)UCB S.A. (Brussels, Belgium)Sun Pharmaceutical Industries Ltd. (Mumbai, India)Other prominent players
Industry Developments:May 2019 –Mayne Pharma Group Limited announced that it has received FDA approval for the use of SORILUX Foam for the treatment of plaque psoriasis. The product is used in treatment of psoriasis of the body & scalp in patients aged 12 years and older.IntroductionResearch ScopeMarket SegmentationResearch MethodologyDefinitions and AssumptionsExecutive SummaryMarket DynamicsMarket DriversMarket RestraintsMarket OpportunitiesKey InsightsPrevalence of Psoriasis and Psoriatic Arthritis for Key Countries/RegionRecent Industry Developments Such as Partnerships, Mergers & Acquisitions, New Product Launches Etc.Pipeline Analysis for Key CompaniesRegulatory Framework by Key CountriesGlobal Reimbursement ScenarioGlobal Psoriasis Treatment Market Analysis, Insights and Forecast, 2016-2027Key Findings / SummaryMarket Analysis, Insights and Forecast – By Drug ClassTNF InhibitorsInterleukinsOthersMarket Analysis, Insights and Forecast – By TypePlaque PsoriasisPsoriatic ArthritisOthersMarket Analysis, Insights and Forecast – By Route of AdministrationOralParenteralTopicalMarket Analysis, Insights and Forecast – By Distribution ChannelHospital PharmaciesRetail PharmaciesOnline pharmaciesMarket Analysis, Insights and Forecast – By RegionNorth AmericaEuropeAsia pacificLatin AmericaMiddle East & AfricaTOC Continued…!!!
Psoriatic Arthritis Treatment Market Size, Share and Global Trend By Drug Class (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies) and Geography Forecast till 2026Dermatitis Drugs Market Size, Share and Global Trend Product By Therapy (Chemotherapy, Radiotherapy, Targeted therapy) By Disease (Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma) By End User(Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centers) and Geography Forecast to 2025Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, Share and Global Trend By Infection Type (Hospital-acquired ABSSSI, Community-acquired ABSSSI), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2026Vitamin D Testing Market Size, Share and Global Trend By Product (25 -Hydroxy Vitamin D Testing, 1,25-Dihydroxy Vitamin D Testing, 24,25-Dihydroxy Vitamin D Testing), By Application(Clinical Testing, Research Testing), By End User(Diagnostic Laboratories, Hospitals & Clinics) and Geography Forecast till 2026Aesthetic/Cosmetic Lasers Market Size, Share & Industry Analysis, By Application (Hair Removal, Pigmentation & Tattoo Removal, Body Shaping & Tightening, Skin rejuvenation, Acne Reduction, and Others), By End User (Hospitals and Specialty Clinics) and Regional Forecast, 2019-2026
Aesthetic Implants Market Size, Share & Industry Analysis, By Product (Breast Implants, Dental Implants, Facial Implants & Others), By Gender (Female, Male), By End-user (Hospitals, Specialty Clinics), and Regional Forecast 2019-2026
Aesthetic Devices Market Size, Share and Global Trend By Product (Aesthetic Laser & Energy Devices, Skin Tightening & Body Contouring Devices, Aesthetic Implants, Facial Aesthetic Devices), By Application (Facial & Body Contouring, Facial & Skin Rejuvenation, Tattoo Removal, Hair Removal, Breast Enhancement), By End User (Hospitals, Dermatology Clinics, Cosmetic Centers, Others), and Geography Forecast till 2026

About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/psoriasis-treatment-market-9212

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.